Bart Newland

Bart is an attorney with extensive and diverse IP and corporate experience. He earned his B.S. degree in Microbiology from UMass Amherst and his JD degree from William and Mary Law School. Bart has been a partner and shareholder in a prominent Washington DC-based law firm, Vice President at Genzyme Corporation, Senior Vice President and Chief IP Counsel at Biogen, and now serves as General Counsel and Corporate Secretary of Atalanta Therapeutics.